Aroa Biosurgery Investor Relations Material
Latest events
H1 2024
Aroa Biosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Aroa Biosurgery Limited
Access all reports
Aroa Biosurgery Limited , a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company offers an injectable dermal substitute, dermadoctor; surgical implants and kits, such as Aroabifix Stapleless, AroaBifix Ultra Nail, AroaBifix2 Inlay, AroaBifix2 Thin Mesh, AroaBifix2 Thin Mesh 2-pack; and a wide range of medical supplies for surgical applications in North America. It also provides water soluble reconstructive meshes for use as surgical implant. The company markets its products through direct sales to hospitals, distributors and surgeons through its field sales offices located in 10 cities throughout the United States.
Key slides for Aroa Biosurgery Limited
H2 2023
Aroa Biosurgery Limited
Q3 2024
Aroa Biosurgery Limited
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇦🇺 Australia